JPMORGAN CHASE & CO - DICE THERAPEUTICS INC ownership

DICE THERAPEUTICS INC's ticker is and the CUSIP is 23345J104. A total of 82 filers reported holding DICE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.20 and the average weighting 1.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of DICE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$28,716,415
+2062.4%
618,089
+1233.3%
0.00%
Q1 2023$1,328,000
+113114.0%
46,357
+23.3%
0.00%
Q4 2022$1,173
-99.8%
37,582
+51.2%
0.00%
Q3 2022$504,000
+62.1%
24,854
+24.3%
0.00%
Q2 2022$311,000
+61.1%
19,990
+98.1%
0.00%
Q1 2022$193,000
-10.2%
10,089
+18.4%
0.00%
Q4 2021$215,0008,5220.00%
Other shareholders
DICE THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Northpond Ventures, LLC 3,292,871$83,343,00029.17%
Sands Capital Ventures, LLC 3,148,970$79,700,00011.81%
OUP Management Co., LLC 536,693$13,584,0006.12%
New Leaf Venture Partners, L.L.C. 556,693$14,090,0005.10%
Logos Global Management LP 1,664,251$42,122,0004.34%
Asymmetry Capital Management, L.P. 185,201$4,687,0002.49%
Deep Track Capital, LP 1,341,004$33,941,0002.40%
RA Capital Management 5,208,911$131,838,0002.32%
Soleus Capital Management, L.P. 810,940$20,525,0002.06%
Miller Investment Management, LP 180,901$4,579,0000.66%
View complete list of DICE THERAPEUTICS INC shareholders